- Country: Brazil
- Summary: Ready-To-Use Antibodies
- BRT Ref No: 128535116
- Deadline: 06 Nov 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 90114/2025
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Object: Electronic Auction - Ready-to-use antibodies
5:00 p.m.
ADDITIVES* CONJUGATED WITH FLUORESCEIN (FITC)
(FITC)
: 10
RABBIT, ANTI HUMAN IGG ACTIVITY, ADDITIONAL CHARACTERISTICS GAMMA CHAIN, ADDITIVES* CONJUGATED WITH FLUORESCEIN (FITC)
10
MOUSE MONOCLONAL TYPE, ANTI HUMAN IGM ACTIVITY
ADDITIONAL ALPHA CHAIN, ADDITIVES* CONJUGATED WITH FLUORESCEIN (FITC)
COLLAGEN IV HUMAN
HUMAN ANTI-IGA ACTIVITY, ADDITIONAL CHARACTERISTICS ALPHA CHAIN, ADDITIVES* CONJUGATED WITH FLUORESCEIN (FITC)
POLICLONAL RABBIT, ACTIVITY****** ANTI HUMAN ALBUMIN, ADDITIVES****** CONJUGATED TO FLUORESCEIN (FITC)
ACTIVITY* HUMAN ANTI ONCOPROTEIN C-ERB-2
EM PARAFFIN, FOR IMMUNOHISTOCHEMISTRY - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINReady-To-Use Antibodies - Brazil Tender
The HOSPITAL DAS CLINICAS OF THE FEDERAL UNIVERSITY OF UBERLANDIA, a Government sector organization in Brazil, has announced a new tender for Ready-To-Use Antibodies. This tender is published on BrazilTenders under BRT Ref No: 128535116 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-11-06.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
